1. Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder

   • Yu-Shu Huang
   • Ming-Horng Tsai

   Leading Article 29 August 2012 Pages: 539 - 554

   

2. Enhancing CNS Repair in Neurological Disease

   • Xiaohua Xu
   • Arthur E. Warrington
   • Moses Rodriguez

   Leading Article 29 August 2012 Pages: 555 - 573

   

3. Transdermal Rivastigmine

   • Jill Greenspoon
   • Nathan Herrmann
   • David N. Adam

   Therapy in Practice 29 August 2012 Pages: 575 - 583

   

4. Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder

   • Anat Abudy
   • Alzbeta Juven-Wetzler
   • Joseph Zohar

   Therapy in Practice 29 August 2012 Pages: 585 - 596

   

5. Issues in the Management of Challenging Behaviours of Adults with Autism Spectrum Disorder

   • Johnny L. Matson
   • Megan Sipes
   • Mary E. Fitzgerald

   Review Article 29 August 2012 Pages: 597 - 606

6. Rituximab for Secondary Progressive Multiple Sclerosis

   • Paulus S. Rommer
   • Robert Patejdl
   • Uwe K. Zettl

   Short Communication 29 August 2012 Pages: 607 - 613

   

7. Vilazodone

   • James E. Frampton

   Adis Drug Profile 29 August 2012 Pages: 615 - 627